Health Care [ 3/12 ] | Biotechnology [ 20/74 ]
NASDAQ | Common Stock
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases.
It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy.
The company was founded in 2018 and is based in Durham, North Carolina.
Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 26 | -0.67 Decreased by -5.12% | -0.63 Decreased by -7.17% |
| Feb 18, 26 | -0.54 Increased by +29.30% | -0.73 Increased by +26.08% |
| Nov 10, 25 | -0.73 Increased by +1.35% | -0.71 Decreased by -2.82% |
| Aug 11, 25 | -0.71 Decreased by -18.33% | -0.70 Decreased by -1.43% |
| May 29, 25 | -0.64 Decreased by -23.08% | -0.71 Increased by +10.11% |
| Feb 10, 25 | -0.76 Decreased by -111.11% | -0.75 Decreased by -1.02% |
| Nov 7, 24 | -0.74 Decreased by -64.44% | -0.60 Decreased by -23.33% |
| Aug 6, 24 | -0.60 Decreased by -5.26% | -0.53 Decreased by -13.21% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by -100.00% | -147.86 M Decreased by -38.90% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -110.64 M Increased by +0.44% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -126.50 M Decreased by -15.93% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -120.61 M Decreased by -38.40% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 160.00 K Decreased by -89.33% | -106.45 M Decreased by -41.33% | Decreased by -66.53 K% Decreased by -1.22 K% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -111.12 M Decreased by -116.11% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -109.12 M Decreased by -86.01% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -87.15 M Decreased by -17.87% | Decreased by N/A% Decreased by N/A% |